Results 241 to 250 of about 24,478 (263)

Caspofungin Therapy of Neonates With Invasive Candidiasis

Pediatric Infectious Disease Journal, 2004
Invasive candidiasis is an increasing problem in neonatal intensive care units worldwide and is an important cause of morbidity, mortality and prolongation of hospital stay. Despite administration of amphotericin B, invasive candidiasis in neonates is sometimes complicated by persistent fungemia and refractory invasive candidiasis. The problem has been
Carlos E Castro, Marco Luis Herrera, Luis E. Pinto, Sergio Vasquez, Roberto Araya, Carla M. Odio, Thomas J. Walsh, Braulio Alfaro, Alberto Saenz   +8 more
openaire   +3 more sources

Rise and fall of Caspofungin: the current status of Caspofungin as a treatment for Cryptococcus neoformans infection

Future Microbiology
Antifungal infections are becoming a major concern to human health due to antimicrobial resistance. Echinocandins have been promising agents against resistant fungal infections, primarily caspofungin, which has a more effective mechanism of action than azoles and polyenes.
Tawanny KB Aguiar, Ana CM Costa, Nilton AS Neto, Daiane MS Brito, Cleverson DT Freitas, João MM Neto, Felipe P Mesquita, Pedro FN Souza   +7 more
openaire   +2 more sources

The use of caspofungin in HIV-infected individuals

Expert Opinion on Investigational Drugs, 2007
Fungal infections are a significant cause of HIV-related morbidity and mortality, particularly in the developing world, but also in countries with access to highly active antiretroviral therapy. New agents are essential to improve present efficacy rates, particularly in cases of drug resistance.
Mark Nelson, Laura Waters
openaire   +2 more sources

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

Clinical Infectious Diseases, 2021
George R Thompson, Alex Soriano, Matteo Bassetti   +2 more
exaly  

caspofungine

2009
Guillaume Chevrel, Virginie Dessus
openaire   +1 more source

Caspofungin acetate, bivalirudin

American Journal of Health-System Pharmacy, 2001
openaire   +2 more sources

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Lancet, The, 2023
exaly  

Caspofungin for Refractory Candidemia in Neonates

The Pediatric Infectious Disease Journal, 2006
Suma Pyati, Medha Kamat, Shabih Manzar
openaire   +2 more sources

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Clinical Infectious Diseases, 2007
Marcio Nucci, Jan J De Waele, Luis L Ostrosky-Zeichner   +2 more
exaly  

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Clinical Infectious Diseases, 2004
Thomas F Patterson, David W Denning
exaly